Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wenxin Keli in Atrial Premature Beats
NCT02319603Phase 4Unknown
- Start
- Jan 2015
- Primary completion
- Feb 2017
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of wenxin keli in Premature atrial contractions (PAC) (2 arms). Primary endpoint: 24 h dynamic electrocardiogram (Holter) premature beat frequency at 4 weeks. Status: unknown.
02
Drugs
wenxin keli
03
Conditions
Premature atrial contractions (PAC)
Beyond the preview
Go deeper on NCT02319603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02319603.